Grown Rogue International (GRUSF) EBT Margin Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) EBT Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 5,267.00 |
| Jul 31, 2023 | 7,487.00 |
| Apr 30, 2023 | 5,542.00 |
| Jan 31, 2023 | 4,080.00 |
| Jan 31, 2022 | 55,474.00 |
| Oct 31, 2021 | 23,625.00 |
| Jul 31, 2021 | 5,610.00 |
| Apr 30, 2021 | 16,359.00 |
| Jan 31, 2021 | 47,503.00 |
| Aug 31, 2017 | -1.25 Mn |
| May 31, 2017 | 580,462.00 |
| Feb 28, 2015 | 444,923.00 |
| Aug 31, 2014 | -113,593.00 |
| May 31, 2014 | -132,308.00 |
| Feb 28, 2014 | 223,923.00 |
| Aug 31, 2013 | 2,886.00 |
| May 31, 2013 | -16,391.00 |
| Feb 28, 2013 | -19,782.00 |
| Aug 31, 2012 | 44,920.00 |
| May 31, 2012 | -42,370.00 |